Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. | The ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Merck's KEYNOTE-B96 trial shows Keytruda with chemotherapy improves survival in platinum-resistant recurrent ovarian cancer ...

Even after Merck & Co.’s Keytruda has climbed to the top of the industry’s sales charts and racked up dozens of FDA-a | A ...

Praxis Precision Medicines (NASDAQ:PRAX) saw its stock soar 100% on Thursday after announcing strong topline data from two ...

In the late-stage MajesTEC-3 trial, Tecvayli plus the subcutaneous formulation of J&J’s antibody drug Darzalex beat ...

Praxis Precision Medicines (NASDAQ:PRAX) added ~134% in the premarket on Thursday after the Boston-based biotech announced ...

EyePoint faces clinical, commercial hurdles despite DME, AMD progress and solid funding through 2027. Read why EYPT stock is ...

Defender will continue to provide security even for unsupported Windows 10 PCs. But Microsoft still wants you to move to Windows 11.

A major pillar of the Voting Rights Act that aims to prevent racial discrimination during the redistricting process is in the ...

Runpod is a cloud platform specializing in GPU-based infrastructure for artificial intelligence applications. The company ...

The Nov. 5 case will decide billions of dollars in trade and significantly influence the country's trade policy.